Youth Access to Naloxone: The Next Frontier?
作者信息
Chadi Nicholas, Hadland Scott E
机构信息
Division of Adolescent Medicine, Department of Pediatrics, Sainte-Justine University Hospital Centre, University of Montreal, Montreal, Quebec, Canada.
Grayken Center for Addiction and Department of Pediatrics, Boston Medical Center, Boston, Massachusetts; Division of General Pediatrics, Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts.
出版信息
J Adolesc Health. 2019 Nov;65(5):571-572. doi: 10.1016/j.jadohealth.2019.08.005.
Abstract
摘要
相似文献
1
Youth Access to Naloxone: The Next Frontier?青少年获取纳洛酮：下一个前沿领域？
J Adolesc Health. 2019 Nov;65(5):571-572. doi: 10.1016/j.jadohealth.2019.08.005.
2
The pharmacist's role in overdose: Using mapping technologies to analyze naloxone and pharmacy distribution.药剂师在药物过量方面的作用：利用地图技术分析纳洛酮及药房分布情况。
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S73-S77.e1. doi: 10.1016/j.japh.2016.11.006. Epub 2017 Jan 19.
3
Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.引导患者提高阿片类药物安全性：基于社区药房的纳洛酮模式。
Harm Reduct J. 2015 Aug 6;12:25. doi: 10.1186/s12954-015-0058-x.
4
Implementing an overdose education and naloxone distribution program in a health system.在一个卫生系统中实施过量用药教育和纳洛酮分发项目。
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S154-S160. doi: 10.1016/j.japh.2017.01.002. Epub 2017 Feb 21.
5
Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina.识别纳洛酮配药的障碍：对北卡罗来纳州社区药剂师的一项调查。
J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4S):S55-S58.e3. doi: 10.1016/j.japh.2018.04.025.
6
Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018.生命体征：2012-2018 年美国基于药房的纳洛酮配药情况。
MMWR Morb Mortal Wkly Rep. 2019 Aug 9;68(31):679-686. doi: 10.15585/mmwr.mm6831e1.
7
Legal changes to increase access to naloxone for opioid overdose reversal in the United States.美国为增加纳洛酮获取途径以逆转阿片类药物过量而进行的法律变革。
Drug Alcohol Depend. 2015 Dec 1;157:112-20. doi: 10.1016/j.drugalcdep.2015.10.013. Epub 2015 Oct 22.
8
Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.与药店纳洛酮相关的信念：基于药店纳洛酮购买者和阿片类药物过量风险人群的定性研究。
J Urban Health. 2019 Jun;96(3):367-378. doi: 10.1007/s11524-019-00349-1.
9
Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses.评估药剂师准备分发纳洛酮和就应对阿片类药物过量提供咨询的能力。
J Am Pharm Assoc (2003). 2019 Jul-Aug;59(4):550-554.e2. doi: 10.1016/j.japh.2019.04.012. Epub 2019 May 17.
10
A standardized team-based approach for identifying naloxone-eligible patients in a grocery store pharmacy.在杂货店药店中采用标准化的基于团队的方法来确定纳洛酮适用患者。
J Am Pharm Assoc (2003). 2019 Jul-Aug;59(4S):S95-S100. doi: 10.1016/j.japh.2019.03.015. Epub 2019 Jun 21.
引用本文的文献
1
Youth and young adult knowledge of and access to opioid harm reduction policies and interventions in North Carolina.北卡罗来纳州青少年和青年对阿片类药物危害减少政策及干预措施的了解与获取情况。
Drug Alcohol Depend Rep. 2024 Jul 30;12:100265. doi: 10.1016/j.dadr.2024.100265. eCollection 2024 Sep.
2
Polysubstance Use among Maryland High School Students: Variations across County-Level School Districts.马里兰州高中生的多物质使用情况：按县学区划分的差异。
Int J Environ Res Public Health. 2024 May 17;21(5):639. doi: 10.3390/ijerph21050639.
3
Interventions to increase naloxone access for undergraduate students: A systematic review of the literature.增加本科生获取纳洛酮机会的干预措施：文献系统综述
J Am Coll Health. 2024 Jan 16:1-9. doi: 10.1080/07448481.2023.2299404.
4
Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use: Evidence from 44 US states.纳洛酮推广与青少年海洛因使用和注射毒品使用的增加无关：来自 44 个美国州的证据。
Int J Drug Policy. 2023 Apr;114:103980. doi: 10.1016/j.drugpo.2023.103980. Epub 2023 Feb 28.
5
Policy Makers' Priorities for Addressing Youth Substance Use and Factors That Influence Priorities.政策制定者解决青少年药物使用问题的优先事项及影响优先事项的因素。
Psychiatr Serv. 2022 Apr 1;73(4):388-395. doi: 10.1176/appi.ps.202000919. Epub 2021 Aug 13.
6
Mental Health Conditions and Substance Use Disorders Among Youth Subsequently Diagnosed With Opioid Use Disorder or Opioid Poisoning.青少年精神健康状况和物质使用障碍与随后诊断为阿片类药物使用障碍或阿片类药物中毒。
J Addict Med. 2022;16(3):357-359. doi: 10.1097/ADM.0000000000000894.
7
"People Don't Just Start Shooting Heroin on Their 18 Birthday": A Qualitative Study of Community Stakeholders' Perspectives on Adolescent Opioid Use and Opportunities for Intervention in Baltimore, Maryland.“人们不会在 18 岁生日那天突然开始注射海洛因”：马里兰州巴尔的摩市社区利益相关者对青少年阿片类药物使用和干预机会的定性研究。
Prev Sci. 2021 Jul;22(5):621-632. doi: 10.1007/s11121-021-01226-7. Epub 2021 Apr 7.
8
Harm Reduction for Adolescents and Young Adults During the COVID-19 Pandemic: A Case Study of Community Care in Reach.减少 COVID-19 大流行期间青少年和青年的伤害：社区关怀中的 Reach 案例研究。
Public Health Rep. 2021 May;136(3):301-308. doi: 10.1177/0033354921999396. Epub 2021 Mar 5.
9
Commentary on Hill et al.: Breaking down barriers-increasing access to lifesaving opioid use disorder medications to save lives.评 Hill 等人的文章：打破障碍——增加救命的阿片类药物使用障碍治疗药物的获取途径以拯救生命。
Addiction. 2021 Jun;116(6):1512-1513. doi: 10.1111/add.15375. Epub 2021 Jan 6.
本文引用的文献
1
Availability of Naloxone in Pharmacies and Knowledge of Pharmacy Staff Regarding Dispensing Naloxone to Younger Adolescents.药店纳洛酮的供应情况以及药店员工对向未成年青少年分发纳洛酮的了解情况。
J Adolesc Health. 2019 Nov;65(5):698-701. doi: 10.1016/j.jadohealth.2019.07.009. Epub 2019 Sep 17.
2
Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018.生命体征：2012-2018 年美国基于药房的纳洛酮配药情况。
MMWR Morb Mortal Wkly Rep. 2019 Aug 9;68(31):679-686. doi: 10.15585/mmwr.mm6831e1.
3
Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.药物和阿片类药物滥用相关的过量死亡-美国，2013-2017 年。
MMWR Morb Mortal Wkly Rep. 2018 Jan 4;67(5152):1419-1427. doi: 10.15585/mmwr.mm675152e1.
4
Youth and the Opioid Epidemic.青年与阿片类药物泛滥
Pediatrics. 2019 Feb;143(2). doi: 10.1542/peds.2018-2752. Epub 2019 Jan 2.
5
Naloxone Availability and Pharmacy Staff Knowledge of Standing Order for Naloxone in Pennsylvania Pharmacies.纳洛酮的可及性和宾夕法尼亚州药店中纳洛酮使用规定的药剂师知识。
J Addict Med. 2019 Jul/Aug;13(4):272-278. doi: 10.1097/ADM.0000000000000492.
6
Identifying Missed Clinical Opportunities in Delivery of Overdose Prevention and Naloxone Prescription to Adolescents Using Opioids.利用阿片类药物识别青少年预防过量用药和开纳洛酮处方中被忽视的临床机会。
J Adolesc Health. 2018 Aug;63(2):245-248. doi: 10.1016/j.jadohealth.2018.05.011.
7
Increasing Naloxone Awareness and Use: The Role of Health Care Practitioners.提高纳洛酮的认知度与使用率：医护人员的作用。
JAMA. 2018 May 22;319(20):2073-2074. doi: 10.1001/jama.2018.4867.
8
Addressing Stigma in Medication Treatment of Adolescents With Opioid Use Disorder.解决青少年阿片类药物使用障碍药物治疗中的污名化问题。
J Addict Med. 2017 Nov/Dec;11(6):415-416. doi: 10.1097/ADM.0000000000000348.
9
Developing harm reduction in the context of youth substance use: insights from a multi-site qualitative analysis of young people's harm minimization strategies.在青少年物质使用背景下制定减少伤害策略：多地点定性分析青少年伤害最小化策略的见解。
Harm Reduct J. 2017 Jul 31;14(1):53. doi: 10.1186/s12954-017-0180-z.
10
Prevention, early intervention, harm reduction, and treatment of substance use in young people.青少年物质使用的预防、早期干预、危害降低及治疗。
Lancet Psychiatry. 2016 Mar;3(3):280-96. doi: 10.1016/S2215-0366(16)00002-X. Epub 2016 Feb 18.
Zotero 插件